Zinc in PDB 6r4t: Crystal Structure of the PRI1 Subunit of Human Primase Bound to Vidarabine Triphosphate
Protein crystallography data
The structure of Crystal Structure of the PRI1 Subunit of Human Primase Bound to Vidarabine Triphosphate, PDB code: 6r4t
was solved by
M.L.Kilkenny,
L.Pellegrini,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
46.69 /
2.35
|
Space group
|
C 2 2 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
111.090,
118.970,
150.720,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.9 /
23.9
|
Other elements in 6r4t:
The structure of Crystal Structure of the PRI1 Subunit of Human Primase Bound to Vidarabine Triphosphate also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of the PRI1 Subunit of Human Primase Bound to Vidarabine Triphosphate
(pdb code 6r4t). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the
Crystal Structure of the PRI1 Subunit of Human Primase Bound to Vidarabine Triphosphate, PDB code: 6r4t:
Jump to Zinc binding site number:
1;
2;
Zinc binding site 1 out
of 2 in 6r4t
Go back to
Zinc Binding Sites List in 6r4t
Zinc binding site 1 out
of 2 in the Crystal Structure of the PRI1 Subunit of Human Primase Bound to Vidarabine Triphosphate
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of the PRI1 Subunit of Human Primase Bound to Vidarabine Triphosphate within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn501
b:68.9
occ:1.00
|
SG
|
A:CYS128
|
2.2
|
77.5
|
1.0
|
SG
|
A:CYS122
|
2.2
|
76.8
|
1.0
|
SG
|
A:CYS121
|
2.2
|
72.3
|
1.0
|
SG
|
A:CYS131
|
2.5
|
63.3
|
1.0
|
HB2
|
A:CYS121
|
3.0
|
90.0
|
1.0
|
HB3
|
A:CYS131
|
3.1
|
76.2
|
1.0
|
HB2
|
A:CYS122
|
3.2
|
93.0
|
1.0
|
CB
|
A:CYS121
|
3.2
|
75.0
|
1.0
|
HB3
|
A:CYS128
|
3.3
|
92.7
|
1.0
|
CB
|
A:CYS122
|
3.3
|
77.5
|
1.0
|
CB
|
A:CYS128
|
3.3
|
77.3
|
1.0
|
H
|
A:CYS131
|
3.3
|
82.2
|
1.0
|
CB
|
A:CYS131
|
3.4
|
63.5
|
1.0
|
H
|
A:CYS128
|
3.5
|
90.1
|
1.0
|
H
|
A:CYS122
|
3.5
|
95.5
|
1.0
|
N
|
A:CYS122
|
3.6
|
79.6
|
1.0
|
N
|
A:CYS128
|
3.7
|
75.1
|
1.0
|
HB2
|
A:LYS130
|
3.8
|
0.8
|
1.0
|
C
|
A:CYS121
|
3.8
|
77.5
|
1.0
|
HD2
|
A:ARG119
|
3.8
|
91.1
|
1.0
|
N
|
A:CYS131
|
3.9
|
68.6
|
1.0
|
HB3
|
A:CYS121
|
4.0
|
90.0
|
1.0
|
CA
|
A:CYS128
|
4.0
|
75.7
|
1.0
|
CA
|
A:CYS122
|
4.0
|
80.1
|
1.0
|
HB3
|
A:CYS122
|
4.1
|
93.0
|
1.0
|
HA
|
A:ILE127
|
4.1
|
85.1
|
1.0
|
HH11
|
A:ARG119
|
4.1
|
79.5
|
1.0
|
HB2
|
A:CYS128
|
4.1
|
92.7
|
1.0
|
CA
|
A:CYS121
|
4.1
|
79.0
|
1.0
|
HB2
|
A:CYS131
|
4.2
|
76.2
|
1.0
|
O
|
A:CYS128
|
4.2
|
78.0
|
1.0
|
CA
|
A:CYS131
|
4.3
|
64.3
|
1.0
|
C
|
A:ILE127
|
4.3
|
68.5
|
1.0
|
H
|
A:LYS130
|
4.3
|
96.4
|
1.0
|
C
|
A:CYS128
|
4.4
|
76.6
|
1.0
|
O
|
A:CYS121
|
4.4
|
76.4
|
1.0
|
HA
|
A:CYS122
|
4.5
|
96.1
|
1.0
|
HE22
|
A:GLN231
|
4.5
|
86.6
|
1.0
|
H
|
A:CYS121
|
4.5
|
99.6
|
1.0
|
CB
|
A:LYS130
|
4.6
|
94.0
|
1.0
|
HB3
|
A:LYS130
|
4.7
|
0.8
|
1.0
|
CD
|
A:ARG119
|
4.7
|
76.0
|
1.0
|
CA
|
A:ILE127
|
4.7
|
70.9
|
1.0
|
C
|
A:LYS130
|
4.8
|
80.3
|
1.0
|
HD3
|
A:ARG119
|
4.8
|
91.1
|
1.0
|
N
|
A:LYS130
|
4.8
|
80.4
|
1.0
|
NH1
|
A:ARG119
|
4.8
|
66.3
|
1.0
|
N
|
A:CYS121
|
4.9
|
83.0
|
1.0
|
HA
|
A:CYS128
|
4.9
|
90.8
|
1.0
|
HA
|
A:CYS121
|
4.9
|
94.8
|
1.0
|
HA
|
A:CYS131
|
4.9
|
77.2
|
1.0
|
CA
|
A:LYS130
|
5.0
|
85.0
|
1.0
|
|
Zinc binding site 2 out
of 2 in 6r4t
Go back to
Zinc Binding Sites List in 6r4t
Zinc binding site 2 out
of 2 in the Crystal Structure of the PRI1 Subunit of Human Primase Bound to Vidarabine Triphosphate
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of the PRI1 Subunit of Human Primase Bound to Vidarabine Triphosphate within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn501
b:71.3
occ:1.00
|
SG
|
D:CYS122
|
2.2
|
78.9
|
1.0
|
SG
|
D:CYS121
|
2.3
|
68.8
|
1.0
|
SG
|
D:CYS128
|
2.3
|
69.7
|
1.0
|
SG
|
D:CYS131
|
2.4
|
62.3
|
1.0
|
HB3
|
D:CYS131
|
2.9
|
73.8
|
1.0
|
HB2
|
D:CYS122
|
3.0
|
96.5
|
1.0
|
HB2
|
D:CYS121
|
3.1
|
86.3
|
1.0
|
CB
|
D:CYS122
|
3.2
|
80.5
|
1.0
|
CB
|
D:CYS131
|
3.3
|
61.5
|
1.0
|
CB
|
D:CYS121
|
3.3
|
71.9
|
1.0
|
H
|
D:CYS131
|
3.3
|
82.0
|
1.0
|
H
|
D:CYS128
|
3.4
|
90.8
|
1.0
|
HB3
|
D:CYS128
|
3.4
|
86.0
|
1.0
|
CB
|
D:CYS128
|
3.4
|
71.7
|
1.0
|
H
|
D:CYS122
|
3.5
|
0.8
|
1.0
|
N
|
D:CYS122
|
3.5
|
84.8
|
1.0
|
N
|
D:CYS128
|
3.6
|
75.7
|
1.0
|
HD2
|
D:ARG119
|
3.8
|
89.1
|
1.0
|
HB2
|
D:LYS130
|
3.8
|
0.0
|
1.0
|
N
|
D:CYS131
|
3.8
|
68.3
|
1.0
|
HH11
|
D:ARG119
|
3.9
|
82.1
|
1.0
|
C
|
D:CYS121
|
3.9
|
75.6
|
1.0
|
HA
|
D:ILE127
|
4.0
|
91.0
|
1.0
|
CA
|
D:CYS122
|
4.0
|
84.0
|
1.0
|
HB2
|
D:CYS131
|
4.0
|
73.8
|
1.0
|
CA
|
D:CYS128
|
4.0
|
74.4
|
1.0
|
HB3
|
D:CYS122
|
4.0
|
96.5
|
1.0
|
HB3
|
D:CYS121
|
4.1
|
86.3
|
1.0
|
CA
|
D:CYS131
|
4.2
|
62.3
|
1.0
|
CA
|
D:CYS121
|
4.2
|
75.0
|
1.0
|
O
|
D:CYS128
|
4.2
|
77.0
|
1.0
|
HB2
|
D:CYS128
|
4.3
|
86.0
|
1.0
|
C
|
D:ILE127
|
4.3
|
72.3
|
1.0
|
C
|
D:CYS128
|
4.4
|
75.4
|
1.0
|
HE22
|
D:GLN231
|
4.4
|
89.7
|
1.0
|
H
|
D:LYS130
|
4.4
|
0.9
|
1.0
|
O
|
D:CYS121
|
4.5
|
78.7
|
1.0
|
HA
|
D:CYS122
|
4.5
|
0.7
|
1.0
|
NH1
|
D:ARG119
|
4.5
|
68.4
|
1.0
|
H
|
D:CYS121
|
4.5
|
93.6
|
1.0
|
CA
|
D:ILE127
|
4.6
|
75.9
|
1.0
|
CB
|
D:LYS130
|
4.6
|
95.9
|
1.0
|
C
|
D:LYS130
|
4.7
|
85.4
|
1.0
|
CD
|
D:ARG119
|
4.7
|
74.3
|
1.0
|
HB3
|
D:LYS130
|
4.8
|
0.0
|
1.0
|
HH12
|
D:ARG119
|
4.8
|
82.1
|
1.0
|
HA
|
D:CYS131
|
4.8
|
74.8
|
1.0
|
HD3
|
D:ARG119
|
4.9
|
89.1
|
1.0
|
N
|
D:LYS130
|
4.9
|
85.8
|
1.0
|
N
|
D:CYS121
|
4.9
|
78.0
|
1.0
|
HA
|
D:CYS128
|
4.9
|
89.2
|
1.0
|
HA
|
D:CYS121
|
5.0
|
90.0
|
1.0
|
CA
|
D:LYS130
|
5.0
|
89.5
|
1.0
|
|
Reference:
S.Holzer,
N.J.Rzechorzek,
I.R.Short,
M.Jenkyn-Bedford,
L.Pellegrini,
M.L.Kilkenny.
Structural Basis For Inhibition of Human Primase By Arabinofuranosyl Nucleoside Analogues Fludarabine and Vidarabine. Acs Chem.Biol. V. 14 1904 2019.
ISSN: ESSN 1554-8937
PubMed: 31479243
DOI: 10.1021/ACSCHEMBIO.9B00367
Page generated: Tue Oct 29 05:58:05 2024
|